Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 3, 2026

IAMGOLD and OneSpaWorld have been highlighted as Zacks Bull and Bear of the Day

View original at finance.yahoo.com
IAMGOLD and OneSpaWorld have been highlighted as Zacks Bull and Bear of the Day For Immediate Release Chicago, IL – March 3, 2026 – Zacks Equity Research shares IAMGOLD IAG as the Bull of the Day and OneSpaWorld OSW as the Bear of the Day…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • If adoption scales meaningfully, crypto-linked debit could drive incremental payment volume through Mastercard's network

    80% confidence
  • When gold prices rise, margins expand fast due to high fixed costs in mining

    80% confidence
  • OneSpaWorld's spa treatments on cruises are discretionary squared, among first expenses cut when consumer confidence wobbles

    80% confidence
  • MetaMask Card allows users to spend directly from wallets without preloading funds onto centralized exchanges with assets remaining in users' control until transaction moment

    80% confidence
  • Gold prices have been living in record territory

    80% confidence
  • Mastercard partnership with MetaMask reinforces strategy of embedding deeper into digital asset ecosystem without taking balance sheet crypto risk

    80% confidence
  • New York regulatory clarity reduces friction and broadens addressable user base for crypto-linked cards

    80% confidence
  • Gold mining stocks are some of the best performing ones out there

    80% confidence
  • IAMGOLD is transitioning from rebuild mode to cash flow mode

    80% confidence
  • OneSpaWorld concentration risk in cruise lines becomes glaring when macro uncertainty increases

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
IAMGOLD and OneSpaWorld have been highlighted as Zacks Bull and Bear of the Day — Source | Via News | ViaNews Market